サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1737114

医療用ガイドワイヤーの世界市場：製品、材料、用途、エンドユーザー、地域別（2026年～2032年）

Medical Guidewire Market By Product, Material, Application, End- User, & Region for 2026-2032

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
医療用ガイドワイヤーの世界市場：製品、材料、用途、エンドユーザー、地域別（2026年～2032年）
出版日: 2025年05月08日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療用ガイドワイヤー市場の評価（2026年～2032年）

世界の死因の上位を占め続ける心血管疾患の有病率の上昇が、医療用ガイドワイヤーの需要を押し上げています。冠動脈疾患、末梢動脈疾患、大動脈瘤などの疾患の症例数が増加するにつれて、それらを特定し治療するための侵襲的な方法に対する需要が高まっています。

医療用ガイドワイヤーに対するニーズの高まりは、心血管疾患の頻度の増加、低侵襲手術の拡大、高齢化社会への人口動態の変化、継続的な技術の進歩など、さまざまな要因の組み合わせによってもたらされ、市場は2024年に7億1,115万米ドルの収益を突破し、2032年には約10億5,872万米ドルの評価額に達すると予測されています。

透視検査や血管内超音波検査（IVUS）などの画像診断の際に、柔軟性、操縦性、視認性に対する要求が高まることで、医療用ガイドワイヤーの需要が急増する可能性が高いです。このような改善されたガイドワイヤー設計の登場は、2026年～2032年にCAGR5.10％で市場が成長することを可能にすることで、多くの医療分野での採用を急増させるのに役立っています。

医療用ガイドワイヤー市場の定義/概要

医療用ガイドワイヤーは、血管形成術やカテーテル治療などの低侵襲医療処置に使用される細くて柔軟なツールです。ステンレス鋼、ニチノール、ポリマー製で、先端が先細りになっており、動脈やその他の解剖学的構造を正確にナビゲートできます。多くの場合、カテーテルによって体内に挿入されるガイドワイヤーは、透視下での複雑な経路を緩やかに進むことができるよう、受動的な構造になっています。

ステントやバルーンカテーテルなど、他の医療機器を挿入する際や療法の出口となります。ガイドワイヤーは、複雑な解剖学的方向への医療機器の安全かつ効率的なナビゲーションを可能にし、低侵襲治療の成功と安全性を向上させます。ステンレス鋼、ニチノール、ポリマーなどの材料で作られたこれらの小型で柔軟なワイヤーは、カテーテル、ステント、その他の医療機器を毛細血管やその他の解剖学的構造内に配置するために受動的に使用されます。これらの用途は、インターベンショナル心臓学、放射線学、泌尿器学、消化器学などの医療分野で広く使われています。

画像モダリティの向上やロボット支援などの技術的進歩により、ガイドワイヤーの使用が補完され、医師は困難な解剖学的システムをより正確かつ安全に操作できるようになると予想されます。医療処置が改善されるにつれ、ガイドワイヤーは低侵襲治療を可能にし、患者の転帰を最大化するという重要な受動的役割を果たし続けると思われます。

この柔軟なワイヤーは、カテーテルやその他の医療器具を循環系やその他の解剖学的経路に正確かつ優しく誘導するためにしばしば使用されます。今後、医療用ガイドワイヤーは設計や材料がさらに進歩し、より繊細で複雑な治療に対応できるようになると予測されています。

当社のレポートには、実用的なデータと将来を見据えた分析が含まれており、ピッチの作成、事業計画の作成、プレゼンテーションの構築、提案書の作成に役立ちます。

低侵襲手術の採用増加は医療用ガイドワイヤー市場を牽引するか？

低侵襲医療処置への需要の高まりは、入院期間の短縮、患者の回復の早さ、処置の安全性と有効性の向上、コストの削減など、従来の開腹手術と比較して治療上大きなメリットがあります。医師は、血管疾患、心臓疾患、泌尿器疾患、腫瘍疾患などの対象疾患を管理するため、より安全で効果的な治療ソリューションを求めるようになっています。低侵襲手術手技がもたらす治療上の利点の結果、医療関係者は従来の開腹手術よりも低侵襲手術手技を選択するようになってきています。

ステンレス鋼やニチノールなどの材料の進歩により、医療用ガイドワイヤーの柔軟性と性能は大幅に向上しました。ガイドワイヤーは、低侵襲手術のニーズの高まりや、心血管疾患の増加に対応して進化し、現在の医療介入における重要なツールとなっています。革新的な設計と材料の進歩により、ガイドワイヤーの柔軟性と性能が向上し、複雑な解剖学的構造をより簡単かつ正確にナビゲートできるようになりました。

外科用ガイドワイヤーのコスト増加は医療用ガイドワイヤー市場の妨げになるか？

市販されている様々なガイドワイヤーは、ニチノール、ステンレス鋼、テフロン、ペリレン、ハイブリッドポリマーなど様々な材料で作られています。特にハイブリッドポリマーは、柔軟性の向上、耐キンク性、引張強度の向上、強力な柱状強度、トルク性能の向上など、いくつかの利点があるため使用されています。しかし、ガイドワイヤー製造にこれらの材料を使用すると、従来の代替品と比較して製品全体のコストが大幅に上昇します。

加えて、先進工業国の中には、特定の低侵襲外科手術に対する支払いが、ガイドワイヤーの費用に対する保険適用を除外している場合があることに注意することが重要です。その結果、このような国々では、高い製品コストと最小限の支払い範囲という組み合わせが、市場拡大の障壁となる可能性があります。

従って、医療用ガイドワイヤー市場の将来は、ヘルスケア関係者にアクセシビリティと購入しやすさを提供しながら、変化する社会経済情勢と技術向上に効果的に対応し、乗り切る業界の能力にかかっています。

目次

第1章 医療用ガイドワイヤーの世界市場のイントロダクション

  • 市場の定義
  • 市場セグメンテーション
  • 調査スケジュール
  • 前提条件
  • 制限事項

第2章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • データの三角測量
  • ボトムアップアプローチ
  • トップダウンアプローチ
  • 調査の流れ
  • 業界専門家による主要な洞察
  • データソース

第3章 エグゼクティブサマリー

  • 市場概要
  • エコロジーのマッピング
  • 絶対的収益機会
  • 市場の魅力
  • 医療用ガイドワイヤーの世界市場の地域別分析（CAGR）
  • 医療用ガイドワイヤーの世界市場：材料別（金額）
  • 医療用ガイドワイヤーの世界市場：用途別（金額）
  • 医療用ガイドワイヤーの世界市場：エンドユーザー別（金額）
  • 今後の市場機会
  • 世界市場内訳
  • 製品ライフライン

第4章 医療用ガイドワイヤーの世界市場の展望

  • 世界の医療用ガイドワイヤーの進化
  • 促進要因
  • 抑制要因
  • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 価格分析
  • マクロ経済分析

第5章 医療用ガイドワイヤーの世界市場：製品別

  • 外科用ガイドワイヤー
  • 診断用ガイドワイヤー

第6章 医療用ガイドワイヤーの世界市場：材料別

  • 概要
  • ニチノール
  • ステンレス鋼
  • ハイブリッド

第7章 医療用ガイドワイヤーの世界市場：用途別

  • 概要
  • 循環器
  • 血管
  • 神経学
  • 腫瘍学
  • その他

第8章 医療用ガイドワイヤーの世界市場：エンドユーザー別

  • 概要
  • 病院、診断センター、外科センター
  • 外来医療センター
  • 研究所・学術機関

第9章 医療用ガイドワイヤーの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第10章 医療用ガイドワイヤーの世界市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展
  • 企業の地域別フットプリント
  • 企業の業界別フットプリント
  • ACEマトリックス

第11章 企業プロファイル

  • Medtronic
  • Boston Scientific
  • C.R. Bard
  • Terumo Corporation
  • Abbott Laboratories
  • B. Braun
  • Johnson & Johnson
  • Stryker Corporation
  • Olympus Corporation
  • Angiodynamics
  • Cook Medical
  • Teleflex Corporation
  • Cardinal Health

第12章 VERIFIED MARKET INTELLIGENCE

  • VERIFIED MARKET INTELLIGENCEについて
  • ダイナミックなデータの可視化
目次
Product Code: 51962

Medical Guidewire Market Valuation - 2026-2032

The rising prevalence of cardiovascular illnesses which continue to be the leading cause of death worldwide is driving up the demand for medical guidewires. As the number of cases of illnesses such as coronary artery disease, peripheral artery disease, and aortic aneurysms increases there is a greater demand for invasive methods to identify and treat them.

The increasing need for medical guidewires is driven by a combination of factors including the rising frequency of cardiovascular diseases, the expansion of minimally invasive procedures, demographic shifts towards an aging population, and ongoing technological advancements that help the market surpass revenue of USD 711.15 Million valued in 2024 and reach a valuation of around USD 1058.72 Million by 2032.

The increasing demand for flexibility, steerability, and visibility during imaging procedures such as fluoroscopy and intravascular ultrasonography (IVUS) is likely to surge demand for medical guidewires. The appearance of such improved guidewire designs helps to their skyrocket their adoption across numerous medical disciplines by enabling the market to grow at a CAGR of 5.10% from 2026 to 2032.

Medical Guidewire Market: Definition/ Overview

A medical guidewire is a thin, flexible tool used in several minimally invasive medical procedures, such as angioplasty and catheterization. It is made of stainless steel, nitinol, or polymer and has a tapered tip that allows for precise navigation through blood arteries or other anatomical structures. The guidewire, which is often put into the body by a catheter has a passive construction that allows it to be progressed gently across complex paths under fluoroscopic guidance.

It provides an outlet for the insertion of other medical devices or therapies, such as stents or balloon catheters. The guidewire enables the safe and efficient navigation of medical equipment through complex anatomical directions, hence improving the success and safety of minimally invasive treatments. These small, flexible wires, made of materials such as stainless steel, nitinol, or polymers, are used passively to help position catheters, stents, or other medical devices within the capillaries or other anatomical structures. Their uses are widespread in medical fields such as interventional cardiology, radiology, urology, and gastrointestinal

Technological advancements such as improved imaging modalities and robotic help are anticipated to supplement the use of guidewires allowing doctors to negotiate difficult anatomical systems more accurately and safely. As medical procedures improve, guidewires will continue to serve an important passive role in enabling minimally invasive therapies and maximizing patient outcomes.

The flexible wires are often used to accurately and gently guide catheters and other medical devices through the circulatory system or other anatomical channels. In the future, medical guidewires are projected to experience additional advances in design and materials, boosting their capabilities for even more delicate and complex treatments.

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Increasing Adoption of Minimally Invasive Surgical Procedures Drive the Medical Guidewire Market?

The increasing demand for minimally invasive medical procedures has significant therapeutic advantages over traditional open operations such as shorter hospital stays, faster patient recovery, increased procedural safety and efficacy, and lower costs. Physicians are increasingly looking for safer and more effective therapeutic solutions to manage target diseases such as vascular disease, cardiology disease, urological disease, and oncology disorders. As a result of the therapeutic benefits provided by minimally invasive surgical techniques, medical professionals are increasingly choosing them over traditional open operations.

The advancements in materials such as stainless steel and nitinol have considerably improved the flexibility and performance of medical guidewires. The guidewires have evolved in response to the growing need for minimally invasive operations and an increasing number of cardiovascular problems making them crucial tools in current medical interventions. Innovative designs and material advances have improved the flexibility and performance of guidewires allowing them to navigate complicated anatomical structures more easily and precisely.

Will the Increasing Cost of Surgical Guidewires Hamper the Medical Guidewire Market?

Various commercially available guidewires are made from a variety of materials including nitinol, stainless steel, Teflon, perylene, and hybrid polymers. Hybrid polymers in particular are used for their several benefits including increased flexibility, resistance to kinking, increased tensile strength, strong columnar strength, and improved torque capabilities. However, the use of these materials in guidewire manufacture greatly increases the overall cost of the product when compared to conventional alternatives.

In addition, it is important to note that in some industrialized countries payments for specific minimally invasive surgical procedures might exclude coverage for the cost of guidewires. As a result, the combination of high product costs and minimal payment coverage prevalent in such countries may serve as a barrier to the market's expansion.

Therefore, the future of the medical guidewire market depends on the industry's capacity to effectively navigate and adapt to the changing socioeconomic landscape and technical improvements while providing accessibility and affordability for healthcare players.

Category-Wise Acumens

Will the Increasing Number of Targeted Medical Procedures Boost the Medical Guidewire Market?

The Nitinol guidewires are expected to be the prominent sector of the guidewires market in terms of material composition. Throughout the forecast period, this segment is expected to remain important. The prediction is supported by several significant elements. For starters, there is a significant trend toward increased use of nitinol guidewires in numerous medical procedures that target certain medical disorders. The growing use of nitinol guidewires in a wide range of medical operations contributes to their expected market dominance. There is a clear need among patients for medical therapies that follow minimally invasive surgical approaches, in which nitinol guidewires play a critical role.

Healthcare providers and patients alike may expect to see the continued use of nitinol guidewires as a key component in guiding medical interventions targeted at improving patient outcomes through easier procedures. The dominant position highlights the importance of nitinol guidewires not just as a technological innovation but also as a crucial enabler of modern medical practices aimed at improving patient care and treatment efficacy. Therefore, the nitinol guidewires segment is expected to dominate the medical guidewire market

Will the Increasing Use of Medical Guidewires Among Cardiologists Drive the Medical Guidewire Market?

The Nitinol, has various favorable qualities, including biocompatibility, resistivity, and flexibility making it ideal for cardiovascular treatments. The features enable cardiologists to navigate complicated arterial structures with precision and ease allowing for minimally invasive procedures. The increasing number of nitinol-based guidewires indicates their dependability and effectiveness in guiding catheters and other medical devices during cardiac interventions which contributes to better patient outcomes and fewer procedural problems. In addition, advances in nitinol manufacturing techniques and design innovations have resulted in guidewires with improved performance and movement increasing their value in cardiology applications.

Cardiologists use guidewires to guide them through complicated arterial structures throughout a variety of cardiovascular procedures including angioplasty, stent implantation, and catheterization of the heart. The need for guidewires in cardiology is driven by the need for precise and minimally invasive procedures to effectively diagnose and treat a wide range of cardiovascular diseases. Therefore, the cardiology segment is poised to maintain its dominance in the medical guidewire market as cardiologists continue to rely on nitinol guidewires for a wide range of diagnostic and therapeutic procedures aimed at managing various cardiovascular conditions.

Country/Region-wise Acumens

Will Rising Incidences of Chronic Diseases Drive the Market in North America?

The increasing incidence of chronic disorders among the region's population is contributing to North America's dominance in the medical guidewire industry. The growing preference for minimally invasive operations over traditional open surgeries has increased demand for medical guidewires. The development highlights the numerous benefits associated with minimally invasive techniques. In addition, the market's expansion is fueled by several technological advances produced through North American R&D projects. These developments have considerably improved the efficacy and safety of medical guidewires, resulting in increased acceptance across a variety of medical procedures.

The increase in chronic diseases emphasizes the need for innovative approaches to healthcare delivery such as less invasive procedures. As a result, the demand for medical guide wires is expected to rise significantly as healthcare providers strive to perform more efficient and effective procedures. Therefore, the influence of increasing chronic disease rates on shaping healthcare in the North American region.

How will the Medical Guidewire Market Favor in Europe?

The significant market shares in the medical guide wire sector are held in Europe due to the regional government's favorable attitudes toward the use of medical guide wires during surgical procedures as well as increased research and development efforts. The growing market share in Europe can be due to rising healthcare costs throughout the area. The passive structure provides for a more thorough representation of market dynamics with an emphasis on the activities and effects that shape the sector rather than specific players. This framework allows for a more detailed understanding of the interactions between the numerous elements influencing the growth of the medical guide wire market in Europe.

The scenario mirrors a broader change in paradigm within European healthcare systems, in which a proactive approach to innovation and technology integration is becoming increasingly important in addressing the issues faced by rising healthcare expenditures. Therefore, the passive construction reveals the deep interplay of diverse forces that shape the course of the European medical guide wire industry, emphasizing its development as a critical component of modern healthcare procedures.

Competitive Landscape

The Medical Guidewire Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the medical guidewire market include:

Acme Monaco

Asahi

Infiniti Medical

Terumo Medical

Abbott Vascular

Shannon MicroCoil

Merit

Biotronik

Custom Wire Technologies

Lepu Meidcal

Cardinal

Shenzhen Yixinda

TE Connectivity

Cook Medical

Medtronic

SP Medical

Integer

Boston Scientific Corporation

Epflex

Hanaco

Medical Guidewire Market, By Category

  • Product:
  • Surgical Guidewires
  • Diagnostic Guidewires
  • Material:
  • Nitinol
  • Stainless Steel
  • Hybrid
  • Application:
  • Cardiology
  • Vascular
  • Neurology
  • Urology
  • Oncology
  • End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Research Laboratories
  • Diagnostic Centers and Surgical Centers
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL GUIDEWIRE MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Medical Guidewire Market Geographical Analysis (CAGR %)
  • 3.6 Global Medical Guidewire Market, By Material (USD Million)
  • 3.7 Global Medical Guidewire Market, By Application (USD Million)
  • 3.8 Global Medical Guidewire Market, By End-User (USD Million)
  • 3.9 Future Market Opportunities
  • 3.10 Global Market Split
  • 3.11 Product Life Line

4 GLOBAL MEDICAL GUIDEWIRE MARKET OUTLOOK

  • 4.1 Global Medical Guidewire Evolution
  • 4.2 Drivers
    • 4.2.1 Driver1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL MEDICAL GUIDEWIRE MARKET, PRODUCT

  • 5.1 Surgical Guidewires
  • 5.2 Diagnostic Guidewires

6 GLOBAL MEDICAL GUIDEWIRE MARKET, BY MATERIAL

  • 6.1 Overview
  • 6.2 Nitinol
  • 6.3 Stainless Steel
  • 6.4 Hybrid

7 GLOBAL MEDICAL GUIDEWIRE MARKET, BY APPLICATION

  • 7.1 Overview
  • 7.2 Cardiology
  • 7.3 Vascular
  • 7.4 Neurology
  • 7.5 Oncology
  • 7.6 Others

8 GLOBAL MEDICAL GUIDEWIRE MARKET, BY END-USER

  • 8.1 Overview
  • 8.2 Hospitals, Diagnostic Centers, and Surgical Centers
  • 8.3 Ambulatory Care Centers
  • 8.4 Research Laboratories & Academic Institutes

9 GLOBAL MEDICAL GUIDEWIRE MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of Latin America
  • 9.6 Middle-East and Africa
    • 9.6.1 UAE
    • 9.6.2 Saudi Arabia
    • 9.6.3 South Africa
    • 9.6.4 Rest of Middle-East and Africa

10 GLOBAL MEDICAL GUIDEWIRE MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Developments
  • 10.4 Company Regional Footprint
  • 10.5 Company Industry Footprint
  • 10.6 ACE Matrix

11 COMPANY PROFILES

  • 11.1 Medtronic
    • 11.1.1 Company Overview
    • 11.1.2 Company Insights
    • 11.1.3 Product Benchmarking
    • 11.1.4 Key Development
    • 11.1.5 Winning Imperatives
    • 11.1.6 Current Focus & Strategies
    • 11.1.7 Threat from Competition
    • 11.1.8 SWOT Analysis
  • 11.2 Boston Scientific
    • 11.2.1 Company Overview
    • 11.2.2 Company Insights
    • 11.2.3 Product Benchmarking
    • 11.2.4 Key Development
    • 11.2.5 Winning Imperatives
    • 11.2.6 Current Focus & Strategies
    • 11.2.7 Threat from Competition
    • 11.2.8 SWOT Analysis
  • 11.3 C.R. Bard
    • 11.3.1 Company Overview
    • 11.3.2 Company Insights
    • 11.3.3 Product Benchmarking
    • 11.3.4 Key Development
    • 11.3.5 Winning Imperatives
    • 11.3.6 Current Focus & Strategies
    • 11.3.7 Threat from Competition
    • 11.3.8 SWOT Analysis
  • 11.4 Terumo Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Insights
    • 11.4.3 Product Benchmarking
    • 11.4.4 Key Development
    • 11.4.5 Winning Imperatives
    • 11.4.6 Current Focus & Strategies
    • 11.4.7 Threat from Competition
    • 11.4.8 SWOT Analysis
  • 11.5 Abbott Laboratories
    • 11.5.1 Company Overview
    • 11.5.2 Company Insights
    • 11.5.3 Product Benchmarking
    • 11.5.4 Key Development
    • 11.5.5 Winning Imperatives
    • 11.5.6 Current Focus & Strategies
    • 11.5.7 Threat from Competition
    • 11.5.8 SWOT Analysis
  • 11.6 B. Braun
    • 11.6.1 Company Overview
    • 11.6.2 Company Insights
    • 11.6.3 Product Benchmarking
    • 11.6.4 Key Development
    • 11.6.5 Winning Imperatives
    • 11.6.6 Current Focus & Strategies
    • 11.6.7 Threat from Competition
    • 11.6.8 SWOT Analysis
  • 11.7 Johnson & Johnson
    • 11.7.1 Company Overview
    • 11.7.2 Company Insights
    • 11.7.3 Product Benchmarking
    • 11.7.4 Key Development
    • 11.7.5 Winning Imperatives
    • 11.7.6 Current Focus & Strategies
    • 11.7.7 Threat from Competition
    • 11.7.8 SWOT Analysis
  • 11.8 Stryker Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Insights
    • 11.8.3 Product Benchmarking
    • 11.8.4 Key Development
    • 11.8.5 Winning Imperatives
    • 11.8.6 Current Focus & Strategies
    • 11.8.7 Threat from Competition
    • 11.8.8 SWOT Analysis
  • 11.9 Olympus Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Insights
    • 11.9.3 Product Benchmarking
    • 11.9.4 Key Development
    • 11.9.5 Winning Imperatives
    • 11.9.6 Current Focus & Strategies
    • 11.9.7 Threat from Competition
    • 11.9.8 SWOT Analysis
  • 11.10 Angiodynamics
    • 11.10.1 Company Overview
    • 11.10.2 Company Insights
    • 11.10.3 Product Benchmarking
    • 11.10.4 Key Development
    • 11.10.5 Winning Imperatives
    • 11.10.6 Current Focus & Strategies
    • 11.10.7 Threat from Competition
    • 11.10.8 SWOT Analysis
  • 11.11 Cook Medical
    • 11.11.1 Company Overview
    • 11.11.2 Company Insights
    • 11.11.3 Product Benchmarking
    • 11.11.4 Key Development
    • 11.11.5 Winning Imperatives
    • 11.11.6 Current Focus & Strategies
    • 11.11.7 Threat from Competition
    • 11.11.8 SWOT Analysis
  • 11.12 Teleflex Corporation
    • 11.12.1 Company Overview
    • 11.12.2 Company Insights
    • 11.12.3 Product Benchmarking
    • 11.12.4 Key Development
    • 11.12.5 Winning Imperatives
    • 11.12.6 Current Focus & Strategies
    • 11.12.7 Threat from Competition
    • 11.12.8 SWOT Analysis
  • 11.13 Cardinal Health
    • 11.13.1 Company Overview
    • 11.13.2 Company Insights
    • 11.13.3 Product Benchmarking
    • 11.13.4 Key Development
    • 11.13.5 Winning Imperatives
    • 11.13.6 Current Focus & Strategies
    • 11.13.7 Threat from Competition
    • 11.13.8 SWOT Analysis

12. VERIFIED MARKET INTELLIGENCE

  • 12.1 About Verified Market Intelligence
  • 12.2 Dynamic Data Visualization